REACH Trial in Africa Program for HIV Prevention

REACH Trial in Africa Program for HIV Prevention

A Phase 2a clinical trial called Reversing the Epidemic in Africa with Choices in HIV Prevention (REACH) will enroll 300 females ages 16 to 21 years at five sites in Kenya, South Africa, Uganda and Zimbabwe.  The study is funded by the National Institutes of Health. ...

Pin It on Pinterest